RxDoctor Payments Data

Adrian Legaspi Sauter, MD

Surgical Oncology · Hialeah, FLNPI 1447257522

Payments from drug & device makers

What this record shows

This record is dominated by other: $111,800 of the $115,828 with a category attached, or 96.5%. Acera Surgical, Inc. accounts for 96.5% of it on its own, with 34 other manufacturers making up the rest. Reporting peaked in 2024 at $112,085 and has fallen 99.7% since, to $298 in 2025. Among surgical oncology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$115,828in general payments, 2019–2025

Across 128 payments — averaging $904.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acera Surgical, Inc.$112K
  • Intuitive Surgical$994
  • Myriad Genetic Laboratories, Inc.$580
  • Sirtex Medical Inc$508
  • Integra Lifesciences Corporation$230
  • Organogenesis Inc.$157
  • plus $2K from 29 others

What the payments were for

  • Food & beverage$3,9603%
  • Education$680%
  • Other$111,80097%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$115,828 in reported general payments places this provider in the 95th percentile of 133 surgical oncology providers in Florida.

See all surgical oncology providers in Florida

Medicare billing

Part B allowed, 2024
$32,818
Medicare patients
63
Services billed
149

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase20$36,600
Megestrol Acetate13$586
Anastrozole20$226
Cefadroxil12$197
Tramadol Hcl29$76

Paid to pharmacies, not to this prescriber.

Other surgical oncology in Hialeah

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →